Advertisement
UK markets closed

  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     

  • HANG SENG

    17,201.27
    +372.34 (+2.21%)
     

  • CRUDE OIL

    82.91
    -0.45 (-0.54%)
     

  • GOLD FUTURES

    2,332.40
    -9.70 (-0.41%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • Bitcoin GBP

    51,351.42
    -1,887.98 (-3.55%)
     

  • CMC Crypto 200

    1,386.43
    -37.67 (-2.64%)
     

  • NASDAQ Composite

    15,712.75
    +16.11 (+0.10%)
     

  • UK FTSE All Share

    4,374.06
    -4.69 (-0.11%)
     
Money:

The five essential pieces of financial paperwork you must never lose

Mislaying key documents can cause real headaches, so it’s worth tracking down these most commonly-lost bits of paperwork

India Pharmaceutical Packaging Market Report 2020-2025 Featuring Key Players - West Pharmaceutical Packaging, Huhtamaki PPL, SGD Pharma, Amcor Flexibles, and Uflex

Research and Markets
·5-min read

Dublin, Sept. 21, 2020 (GLOBE NEWSWIRE) -- The "India Pharmaceutical Packaging Market - Growth, Trends, and Forecasts (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering.

The India pharmaceutical packaging market is expected to grow at a CAGR of 5% over the forecast period 2020 to 2025

The growing population, rising health awareness, increasing life expectancy can be attributed to the growth of the pharmaceuticals packaging industry. Moreover, growing awareness of environmental issues due to traditional packaging material and the adoption of new regulatory standards for packaging recycling is also driving the pharmaceutical packaging industry in India.

Key Market Trends

Indian Pharmaceutical Exports is Expected to Hold Significant Market

  • India is the third-largest pharmaceuticals in terms of volume and thirteenth most significant in terms of value as it has a large raw material base and availability of a skilled workforce. According to the India Brand Equity Foundation, India's pharmaceutical export stood at USD 19.13 billion in 2018-2019, reached USD 13.69 billion in 2019-2020 (till January 2020) and is expected to grow by 30% to reach USD 20 billion by the end of 2020.

  • The country has one of the lowest manufacturing costs in the world, more economical than that of the USA and almost half of Europe, it is the largest supplier of generic medicines in the world (20% to 22%of global export volume). It has fueled the research and development of efficient packing solutions for the pharmaceutical sector that substantially prevents contamination, provides drug safety, and convenience of delivery and handling.

  • Moreover, India imports 70% of APIs from China and to safeguard the country, on March 3rd, 2020, India has restricted the export of 26 active pharmaceutical ingredients (API) and medicines due to the impact of coronavirus COVID-19 in China, that accounts 10% of all exports from the country. This has caused a panic in European countries as 26% of the European formulations are controlled by Indian APIs. But the Indian government has partly lifted the restriction to export for two drugs, hydroxychloroquine (HCQ), an anti-malarial drug considered suitable for the treatment of COVID-19, and paracetamol. This has again increased the demand for better pharmaceutical secondary and tertiary packaging market in India.

Plastic Packaging Will Experience Significant Growth

  • Plastic bottles used for pharma packaging are made of a variety of plastic such as polyvinyl chloride, polyethylene, polypropylene, and polystyrene. It is a clear, strong, and lightweight plastic that is also used for storing and selling packaged products across the industry, such as drinking water, carbonated soft drinks, and soda, etc. They are mostly used as primary and secondary packaging material.

  • Pharmaceutical companies are relying more on packaging and labeling as media to promote and protect their products in the increasing counterfeit market and to meet the new safety regulations. Plastics packaging has gained popularity due to its properties such as barrier against moisture, high dimensional stability, high impact strength, resistance to strain, low water absorption, transparency, resistance to heat and flame, etc.

  • Polyvinyl chloride and PVDC (polyvinylidene chloride) are mostly used in pharmaceuticals as primary packaging materials that protect the pharmaceutical products against oxygen and odor, moisture, water vapor transmission, contamination, and bacteria. It makes both PVC and PVDC the material of choice for blister packaging. PVC is the third most widely produced synthetic plastic polymer used across the globe as it has excellent organoleptic properties, which means it does not affect the taste of the packaged food or medicine. PVC mono films protect against contamination by helping to prevent the spread of germs during manufacture, distribution, and display and are sunlight and UV rays resistant.

ADVERTISEMENT

Competitive Landscape

The India pharmaceutical packaging market is fragmented and is dominated by a few major players like West Pharmaceutical Packaging India Pvt. Ltd., Huhtamaki PPL Ltd, SGD Pharma India Ltd, Amcor Flexibles India Pvt Ltd, and Uflex Limited. These major players, with a prominent share in the market, are focusing on expanding their customer base across foreign countries.

These companies are leveraging strategic collaborative initiatives to increase their market share and increase their profitability. However, with technological advancements and product innovations, mid-size to smaller companies are increasing their market presence by securing new contracts and by tapping new markets.

  • January 2020 - Huhtamaki PPL Ltd had completed the acquisition of Mohan Mutha Polytech Private limited's flexible packaging business. The acquisition would allow Huhtamaki to speed up its growth in India by improving its capacity to serve customers in South India.

Key Topics Covered:

1 INTRODUCTION

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Awareness of Environmental Issues and Adoption of New Regulatory Standards
4.2.2 Surging Number of Chronic Disease Cases in India
4.3 Market Restraints
4.3.1 Fluctuations in Raw Material Cost Due to Suppliers Bargaining Power
4.4 Value Chain / Supply Chain Analysis
4.5 Porter's Five Force Analysis
4.6 Assessment of COVID-19 Impact on the Industry

5 MARKET SEGMENTATION
5.1 Material Type
5.1.1 Plastic
5.1.2 Glass
5.1.3 Others (Paper & Paperboard, Metal)
5.2 Product Type
5.2.1 Bottles
5.2.2 Vials & Ampoules
5.2.3 Syringes
5.2.4 Tubes
5.2.5 Caps & Closures
5.2.6 Pouches
5.2.7 Labels
5.2.8 Other Product Types

6 COMPETITIVE LANDSCAPE
6.1 Vendor Market Share
6.2 Mergers & Acquisitions
6.3 Company Profiles
6.3.1 West Pharmaceutical Packaging India Pvt. Ltd.
6.3.2 Huhtamaki PPL Ltd
6.3.3 SGD Pharma India Ltd
6.3.4 Uflex Limited
6.3.5 Amcor Flexibles India Pvt Ltd
6.3.6 Essel Propack Ltd
6.3.7 Parekhplast India Limited
6.3.8 Regent Plast Pvt Ltd.
6.3.9 Graham Blow Pack Pvt. Limited
6.3.10 Hoffmann Neopac AG

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

For more information about this report visit https://www.researchandmarkets.com/r/8py6zr

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900